Ticketmaster planning to verify if fans have received a COVID-19 vaccine or tested negative before concerts


Whenever it's possible to attend large concerts again, it seems proof that you've received a COVID-19 vaccine — or at least tested negative for the coronavirus — will be a requirement.
Ticketmaster is working on a plan to use "smart phones to verify fans' vaccination status or whether they've tested negative for the coronavirus within a 24 to 72 hour window" before they can attend events once concerts return, Billboard reported on Wednesday.
This would evidently entail having a third party health pass company verify a person's vaccination status, or verify that they've recently tested negative for the coronavirus, after they purchase a ticket. Once that has been confirmed, Ticketmaster, which wouldn't have access to medical records, would issue the necessary credentials. But "if a fan tested positive or didn't take a test to verify their status, they would not be granted access to the event," Billboard says.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Ticketmaster President Mark Yovich told Billboard that "we're already seeing many third-party health care providers prepare to handle the vetting — whether that is getting a vaccine, taking a test, or other methods of review and approval — which could then be linked via a digital ticket so everyone entering the event is verified." He added that the company hopes to "provide enough flexibility and options that venues and fans have multiple paths to return to events."
News of Ticketmaster's plan comes after Pfizer announced this week that an early analysis suggested its COVID-19 vaccine candidate is more than 90 percent effective, although it still needs to be proven to be safe and approved by the Food and Drug Administration. If it does get approved, Dr. Anthony Fauci, the nation's top infectious disease expert, has predicted that the average person may be able to get it by April 2021.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
5 educational cartoons about the Harvard pushback
Cartoons Artists take on academic freedom, institutional resistance, and more
By The Week US
-
One-pan black chickpeas with baharat and orange recipe
The Week Recommends This one-pan dish offers bold flavours, low effort and minimum clean up
By The Week UK
-
Merz's coalition deal: a 'betrayal' of Germany?
Talking Point With liberalism, freedom and democracy under threat globally, it's a time for 'giants' – but this is a 'coalition of the timid'
By The Week UK
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
By Peter Weber, The Week US
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
By Justin Klawans, The Week US
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
By Peter Weber, The Week US
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US